Jieming Zhang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Fotemustine-containing chemotherapy suggests lower toxicity with comparable efficacy versus high-dose methotrexate-based regimens: a retrospective cohort analysis.

Journal: Therapeutic advances in medical oncology

Published: September 04, 2025

Tumor-Specific Activatable Nanopaltform Achieves Oxidative Stress Amplification and Reversal of Cisplatin Resistance to Provoke Enhanced Ferroptosis-Apoptosis Cancer Therapy.

Tumor-Specific Activatable Nanopaltform Achieves Oxidative Stress Amplification and Reversal of Cisplatin Resistance to Provoke Enhanced Ferroptosis-Apoptosis Cancer Therapy.

Journal: Molecular pharmaceutics

Published: June 12, 2025

Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma.

Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma.

Journal: Frontiers in immunology

Published: August 15, 2024

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma.

Journal: Aging

Published: August 01, 2023

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: June 16, 2022

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.

Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.

Journal: Frontiers in endocrinology

Published: May 20, 2022

HDAC6-specific inhibitor alleviates hashimoto's thyroiditis through inhibition of Th17 cell differentiation.

HDAC6-specific inhibitor alleviates hashimoto's thyroiditis through inhibition of Th17 cell differentiation.

Journal: Molecular immunology

Published: November 15, 2021

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial.

Journal: Cancer biology & medicine

Published: October 11, 2021

Some Possible Confounders in Study of Patient Age and Progression of Low-risk Papillary Thyroid Carcinoma.

Some Possible Confounders in Study of Patient Age and Progression of Low-risk Papillary Thyroid Carcinoma.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 17, 2020

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study.

Journal: Drug design, development and therapy

Published: August 16, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026